Sellbyville, DE -- (SBWIRE) -- 10/10/2018 -- Home Infusion Therapy Market size is set to exceed USD 28 billion by 2024; according to a new research report by Global Market Insights, Inc.

Increasing demand for homecare facilities and growing number of hospital acquired infections, will drive industry growth over the forecast period. Rapid developments in antibiotics and medications used in chemotherapy will further boost the business revenue.

Increasing number of infusion applications, growing chronic disease prevalence and rising public and private funding on medical goods and services will fuel home infusion therapy market size. Favorable government initiatives will encourage cancer treatments and boost industry expansion.

Inadequate reimbursement for home infusion therapies and lack of non-uniform and complex reimbursement framework may hamper business growth.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/435

Infusion pump should fuel revenue growth in 2016 due to growing availability of smart pumps and high level of accuracy and precision of these devices. Needleless connectors should witness lucrative growth owing to its rising demand over the coming years.

Enteral nutrition should witness lucrative growth owing to its ability to provide timely nutrition in home setting. Increasing number of chronic diseases and growing geriatric population will stimulate industry expansion over the forecast years.

U.S. home infusion therapy market will grow at a substantial rate over the forecast period. Presence of leading industry players coupled with growing homecare facilities will stimulate business growth. Growing prevalence of cancer and rising incidence of hospital acquired infections (HAI's) will fuel industry expansion.

UK home infusion therapy market will witness significant growth due to growing number of cardiovascular diseases and increasing prevalence of malnutrition. Increasing demand for home infusion therapy products in rehabilitation and orthopedic applications

India will witness considerable growth owing to increasing chronic disease prevalence coupled with rising number of hospital acquired infections (HAI's). Supportive initiatives by organizations to raise standard of care in infusion therapy and technological advancements will boost infusion therapy products demand.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/435

Some of the prominent business players are B. Braun Melsungen, Baxter International, Caesarea Medical Electronics, CareFusion Corporation, Fresenius Kabi, ICU Medical, JMS, Smiths Medical, and Terumo Corporation. Companies implement strategy such as, mergers, technological advancement and new product development to enlarge the product portfolio and enhance their leadership position in industry.